Baird Medical Investment Holdings (BDMD) Non-Current Deffered Revenue (2023)
Baird Medical Investment Holdings' (BDMD) quarterly Non-Current Deffered Revenue came in at $875258.0 in Q4 2023.
Powered by 
Analysis
Baird Medical Investment Holdings (BDMD) Non-Current Deffered Revenue (2023) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Non-Current Deffered Revenue for 1 consecutive years, with $875258.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $875258.0 in Q4 2023; TTM through Dec 2023 was $875258.0, a N/A change from a year earlier, with the FY2023 full-year figure at $875258.0, changed N/A from the prior year.
- Non-Current Deffered Revenue was $875258.0 for Q4 2023 at Baird Medical Investment Holdings.
- Over five years, Non-Current Deffered Revenue peaked at $875258.0 in Q4 2023 and troughed at $875258.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Baird Medical Investment Holdings | 29.74 Mn | 29.45 Mn | - | - |